# Feasibility Study of a New Screening Program for Major Aneuploidies (T21, T18, T13) in the Emilia-Romagna Region (SAPERER)

> **NCT04437992** · — · UNKNOWN · sponsor: **Azienda Usl di Bologna** · enrollment: 7000 (estimated)

## Conditions studied

- Autosomal Aneuploidy

## Interventions

- **GENETIC:** NIPT

## Key facts

- **NCT ID:** NCT04437992
- **Lead sponsor:** Azienda Usl di Bologna
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-27
- **Primary completion:** 2021-04-27
- **Final completion:** 2021-04-27
- **Target enrollment:** 7000 (ESTIMATED)
- **Last updated:** 2020-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04437992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04437992, "Feasibility Study of a New Screening Program for Major Aneuploidies (T21, T18, T13) in the Emilia-Romagna Region (SAPERER)". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04437992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*